Walgreens is rolling out a billing solution that will allow Medicare patients using Dexcom’s G6 continuous glucose monitoring device to fill their prescription at any of its 9,200 pharmacies.
Patients with diabetes continue to grapple with such perennial problems as blood glucose monitoring, safe injection, and disposal of the sharps they create every day.
Higi, in partnership with the American Diabetes Association, now is offering a free self-service Type 2 diabetes risk assessment that combines station measurements with a consumer-reported health survey.
GMDC|Retail Tomorrow and Hamacher Resource Group shared with Drug Store News some insights into the shoppers with diabetes from their new Selfcare Roadmap tool.
The Dexcom G6 device update lets iOS users have their glucose readings read aloud by Siri and instantly display graphs in the lock screen, the company said.
WOONSOCKET, R.I. — CVS/pharmacy has introduced a new CVS/pharmacy Brand Advanced Glucose Meter, a Food and Drug Administration-approved meter for at-home glucose monitoring.
Semma Therapeutics has announced the completion of a highly oversubscribed $114 million Series B financing. Proceeds will be used to bring the company’s lead development program of encapsulated stem cell-derived islets, through proof-of-concept in patients while continuing exploration of other regenerative medicine therapeutics.
In the initial launch of the higi-Epic EHR integration, Rush patients who receive specialized care for hypertension will be able to measure their biometrics at one of 211 Chicago-area pharmacy locations.
The Contour Next One blood glucose monitoring system can connect to mobile devices via Bluetooth to facilitate easier management within the Contour Diabetes app.
